Le Lézard
Classified in: Health
Subject: SVY

Global Sexual Wellness Market 2018-2022


LONDON, June 20, 2018 /PRNewswire/ -- About Sexual Wellness

Sexual wellness refers to the physical, mental, and sexual well-being of people. Products such as erotic lingerie, condoms and contraceptives, personal lubricants, sex toys, and others such as testing cards and pregnancy testing kits, sexual enhancement supplements, sex games, and vaginal sexual wellness products, which enhance safety and pleasure of sexual experiences, are considered sexual wellness products.

Download the full report: https://www.reportbuyer.com/product/2720183

Technavio's analysts forecast the global sexual wellness market to grow at a CAGR of 6.72% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global sexual wellness market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of various sexual wellness products through retail stores and online platforms.

The market is divided into the following segments based on geography:
? Americas
? APAC
? EMEA

Technavio's report, Global Sexual Wellness Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
? Church and Dwight
? Doc Johnson
? Karex Berhad
? Lifestyles Holdco
? LELO
? Reckitt Benckiser

Market driver
? Availability of products online
? For a full, detailed list, view our report

Market challenge
? Social stigma and legal complications
? For a full, detailed list, view our report

Market trend
? Growing LGBT population
? For a full, detailed list, view our report

Key questions answered in this report
? What will the market size be in 2022 and what will the growth rate be?
? What are the key market trends?
? What is driving this market?
? What are the challenges to market growth?
? Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Download the full report: https://www.reportbuyer.com/product/2720183

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +1 (718) 213 4904
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: